Start Date
February 28, 2003
Primary Completion Date
October 31, 2007
Study Completion Date
February 29, 2008
ipilimumab
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda
National Cancer Institute (NCI)
NIH
National Institutes of Health Clinical Center (CC)
NIH